| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 20.2 | 14.6 |
| Gross profit | 7.9 | 3.5 |
| Profit before tax | 3.9 | -1.0 |
| Net income | 3.7 | -1.0 |
| EPS (diluted, $ a share) | $0.05 | $-0.01 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +38.1% |
|---|---|
| Gross margin | 39.3% |
| Operating margin | 20.0% |
10-Q filed with the SEC, NASDAQ: SLSN. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Solesence, Inc.: key numbers
- Share price
- $1.60Close, Nov 16
- Market cap
- $113M
- Shares outstanding
- 70.65MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Perfumes, Cosmetics & Other Toilet PreparationsSIC 2844
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Solesence, Inc.
All →Solesence Earnings Call: Key Takeaways
Solesence achieved record Q3 revenue and net income driven by lean management initiatives, though management lowered full-year EBITDA margin guidance due to first-half weakness.
- Call
- Nov 12, 2026, 5:00 PM ET
Solesence Financial Results
Solésence reported record third quarter 2026 financial results, with revenue increasing 38% year-over-year to $20.2 million. The company achieved its highest-ever quarterly net income of $3.7 million, driven by operational excellence and strong demand from brand partners.
- Term
- Q3 2026
“We’re very pleased that Solésence delivered solid top line growth as well as steady operational and strategic progress in the third quarter, driven by key milestones across our Transform and Transcend framework. Most notably, we reached a major turning point by completing the primary investment and implementation phase of our first pillar, operational excellence. This elevated capacity and efficiency position us to meet robust demand from our brand partners today while seamlessly scaling for tomorrow. Paired with our continued innovation in novel formulations and expanding global presence, Solésence is uniquely positioned to deliver long-term, profitable growth and lead the market in meeting evolving consumer needs.”
Kevin Cureton, President and CEO
“By pairing record revenue and net income with strong margin expansion, we have positioned Solésence for sustained growth. The operational and financial improvements achieved throughout 2026 provide a strong foundation as we look ahead to 2027.”
Laura Riffner, Chief Financial Officer
Solesence Debt Financing Update with Beachcorp, LLC
Solésence, Inc. entered into amendments for three separate loan agreements with affiliates of its controlling shareholder, Bradford T. Whitmore. The amendments extend the maturity dates for the Term Loan, A/R Loan, and Revolving Loan from April 30, 2027, to May 31, 2028.
- Counterparty
- Beachcorp, LLC
- Term
- through May 31, 2028
Solesence Nasdaq/NYSE Compliance Notice
Solésence, Inc. received a deficiency notice from Nasdaq on September 29, 2026, because its common stock closing bid price fell below the $1.00 minimum requirement for 30 consecutive trading days. The company has 180 calendar days, until March 29, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive trading days. If compliance is not met by then, the company may be eligible for an additional 180-day grace period if it meets other listing standards.
- Counterparty
- Nasdaq
- Term
- 180 days